Why the Europe Pharmacogenetics Testing in Psychiatry/Depression...

ha aggiunto una foto Altre informazioni

2025-12-23 08:31:45 -

Why the Europe Pharmacogenetics Testing in Psychiatry/Depression Market Is Growing with Precision Healthcare Adoption

"Market Trends Shaping Executive Summary Europe Pharmacogenetics Testing in Psychiatry/Depression Market Size and Share CAGR Value Data Bridge Market Research analyzes that the Europe pharmacogenetics testing in psychiatry/depression market is expected to reach the value of USD 648.50 million by 2029, at a CAGR of 8.9% during the forecast period A complete discussion about numerous...

0 Commenti 0 condivisioni 146 Views